Champions Oncology Inc.

CSBR | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.81

$0.00 (0.00%)

At close: Oct 30, 2026, 4:00 PM ET

$4.81

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q1 2027 Jul 31, 2026	Q4 2026 Apr 30, 2026	Q3 2026 Jan 31, 2026	Q2 2026 Oct 31, 2025	Q1 2026 Jul 31, 2025	Q4 2025 Apr 30, 2025	Q3 2025 Jan 31, 2025	Q2 2025 Oct 31, 2024	Q1 2025 Jul 31, 2024	Q4 2024 Apr 30, 2024	Q3 2024 Jan 31, 2024	Q2 2024 Oct 31, 2023	Q1 2024 Jul 31, 2023	Q4 2023 Apr 30, 2023	Q3 2023 Jan 31, 2023	Q2 2023 Oct 31, 2022	Q1 2023 Jul 31, 2022	Q4 2022 Apr 30, 2022	Q3 2022 Jan 31, 2022	Q2 2022 Oct 31, 2021	Q1 2022 Jul 31, 2021
Revenue	60.66M	59.43M	57.94M	58.42M	56.88M	56.94M	58.59M	53.57M	51.66M	50.16M	49.22M	49.98M	52.69M	53.87M	53.68M	54.1M	51.6M	49.11M	46.8M	44.42M	42.75M
Cost of Revenue	30.75M	30.9M	31.36M	29.15M	29.31M	28.39M	28.37M	29.6M	28.79M	29.4M	29.49M	29.34M	30.16M	29.53M	28.42M	27.12M	25.29M	23.63M	23.04M	21.25M	21.29M
Gross Profit	29.91M	28.53M	26.58M	29.28M	27.57M	28.56M	30.22M	23.97M	22.87M	20.75M	19.74M	20.64M	22.52M	24.34M	25.26M	26.97M	26.31M	25.48M	23.76M	23.16M	21.46M
Operating Income	-1.04M	-1.14M	-2.22M	2.46M	3.01M	4.85M	6.29M	-787K	-3.47M	-7.36M	-9.61M	-9.49M	-7.52M	-5.26M	-3.05M	242K	498K	607K	489K	641K	385K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-892K	-929K	-2.4M	2.36M	2.84M	4.63M	6.4M	-636K	-3.44M	-7.31M	-9.66M	-9.56M	-7.5M	-5.27M	-3.07M	148K	439K	583K	507K	683K	410K
Net Income	-1.14M	-1.18M	-2.28M	2.49M	2.92M	4.7M	6.43M	-598K	-3.4M	-7.28M	-9.73M	-9.64M	-7.58M	-5.34M	-3.12M	108K	401K	548K	438K	610K	334K
Selling & General & Admin	21.81M	20.47M	19.87M	18.44M	17.1M	16.89M	16.59M	16.95M	17.7M	18.13M	18.19M	17.96M	17.79M	17.24M	17.02M	16.47M	15.86M	15.5M	14.42M	13.97M	13.17M
Research & Development	9.35M	9.08M	8.93M	8.38M	7.45M	6.83M	6.91M	7.38M	8.2M	9.54M	10.35M	11.36M	11.45M	11.55M	11.28M	10.26M	9.96M	9.37M	8.85M	8.55M	7.9M
Other Expenses	-203K	111K	n/a	n/a	n/a	n/a	435K	435K	435K	435K	807K	807K	807K	807K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	30.95M	29.67M	28.81M	26.82M	24.56M	23.71M	23.94M	24.76M	26.34M	28.11M	29.34M	30.13M	30.05M	29.59M	28.31M	26.73M	25.82M	24.87M	23.27M	22.52M	21.07M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	10.55M	9.32M	8.83M	7.97M	7.72M	7.55M	7.01M	7M	7.05M	7.06M	7.14M	7.1M	7.01M	7M	6.77M	6.56M	6.5M	6.38M	6.24M	6.18M	5.89M
Cost & Expenses	61.7M	60.57M	60.17M	55.96M	53.87M	52.1M	52.3M	54.36M	55.13M	57.51M	58.83M	59.46M	60.21M	59.13M	56.72M	53.85M	51.1M	48.5M	46.31M	43.77M	42.36M
Income Tax Expense	243K	246K	-55K	-74K	-81K	-74K	-26K	-38K	-38K	-31K	70K	76K	79K	68K	46K	40K	38K	35K	69K	73K	76K
Shares Outstanding (Basic)	13.9M	13.83M	13.89M	13.79M	13.79M	13.75M	13.7M	13.59M	13.59M	13.59M	13.59M	13.5M	13.51M	13.54M	13.55M	13.53M	13.52M	13.28M	13.5M	13.43M	13.4M
Shares Outstanding (Diluted)	13.9M	13.83M	13.89M	14.46M	13.79M	13.75M	14.36M	14.02M	14.04M	13.59M	13.59M	13.5M	13.51M	13.54M	13.56M	13.53M	13.52M	13.51M	14.39M	14.55M	13.4M
EPS (Basic)	-0.08	-0.08	-0.16	0.19	0.22	0.35	0.47	-0.05	-0.25	-0.54	-0.72	-0.71	-0.56	-0.39	-0.23	0.01	0.03	0.04	0.03	0.04	0.02
EPS (Diluted)	-0.08	-0.08	-0.16	0.17	0.20	0.33	0.45	-0.05	-0.25	-0.54	-0.72	-0.71	-0.56	-0.39	-0.23	0	0.02	0.04	0.03	0.04	0.02
EBITDA	447K	448K	-948K	3.86M	4.39M	6.27M	8.46M	1.5M	-1.21M	-5.09M	-6.84M	-6.65M	-4.51M	-2.19M	-841K	2.2M	2.28M	2.21M	1.86M	1.95M	1.63M
EBIT	-886K	-929K	-2.4M	2.36M	2.84M	4.63M	6.76M	-282K	-3.08M	-6.95M	-8.83M	-8.73M	-6.68M	-4.44M	-3.07M	148K	439K	583K	500K	684K	402K
Depreciation & Amortization	1.33M	1.38M	1.45M	1.51M	1.55M	1.64M	1.7M	1.79M	1.87M	1.87M	1.99M	2.09M	2.16M	2.25M	2.23M	2.05M	1.84M	1.63M	1.36M	1.26M	1.22M